MAPT and Alzheimer disease: Moreover, when tau pathology is found to be self-propagating and amyloid pathology itself drives tau pathology, which was observed in different animal AD models, then it may be crucial to administer the patients an early immunotherapy in the attempt of achieving positive clinical outcomes.